Not currently recruiting at UC Health
A Study to Find Out if Selexipag is Effective and Safe in Patients With Chronic Thromboembolic Pulmonary Hypertension When the Disease is Inoperable or Persistent/Recurrent After Surgery
a study on Chronic Thromboembolic Pulmonary Hypertension High Blood Pressure
Summary
- Eligibility
- for people ages 18-85 (full criteria)
- Location
- at UCLA UCSF
- Dates
- study startedestimated completion
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Actelion
- Links
- To learn how to participate in this trial please click here.
- ID
- NCT03689244
- Phase
- Phase 3
- Study Type
- Interventional
- Last Updated